Page 79 - Contract Development News Today

/PRNewswire/ -- Snapdragon Chemistry today announced its proposed acquisition by Asymchem (stock code: 002821.SZ/6821.HK), a leading CDMO serving the global...

/PRNewswire/ -- The Medical Device Outsourcing Market is Segmented by Type (Finished Goods, Electronics, Raw Materials), Application (Cardiology, Diagnostic...

Global CDMO's Heidelberg Facility Supplies more pDNA material to help address growing needsHeidelberg, Germany, Feb. 08, 2022, a leading global Biopharmaceutical Contract Development and Manufacturing

Investegate announcements from AGC Biologics, AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

Philadelphia has built its current life sciences boom on innovations in cell and gene therapy, but other markets are on the citys heels.

- Construction of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing and aseptic fill/finish facility in Grangemouth, Scotland and...

- Construction of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing and aseptic fill/finish facility in Grangemouth, Scotland and...

Merck KGaA (MKGAF) announced organizational changes and a new operating model for its growth strategy.Existing Contract Development and Manufacturing Organization ((CDMO)) and...

- Construction of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing and aseptic fill/finish facility in Grangemouth, Scotland and enhancement of existing Active Pharmaceutical

The partnership will provide MaaT Pharma with a dedicated 1,500 square meter site, with the potential for double if needed, in order to increase its cGMP manufacturing capacities to support clinical